Form 8-K · Current report
A. O. Smith 8-K, filed Jul 30, 2026
- Filed
- CIK
- 0000091142
- Accession no.
- 0000091142-26-000096
Summary
A. O. Smith reported second-quarter 2026 net sales of $1.004 billion, down 1% year over year, with net earnings of $124.9 million and diluted EPS of $0.91. The company narrowed its full-year 2026 sales growth outlook to 2%–3% and adjusted EPS outlook to $3.70–$3.85, and increased its full-year share repurchase target to $300 million from $200 million.
Key points
- Second-quarter 2026 net sales were $1.004 billion, down 1% year over year, and net earnings fell 18% to $124.9 million.
- North America segment sales rose 5% to $820.5 million, helped by 21% boiler sales growth and a $16 million contribution from the January 2026 Leonard Valve acquisition, partly offset by lower residential water heater volumes.
- Rest of World segment sales fell 19% to $194.9 million, with China sales down 28% in local currency amid continued weak consumer demand.
- A. O. Smith narrowed its full-year 2026 sales growth guidance to 2%–3% from 2%–4% and adjusted EPS guidance to $3.70–$3.85 from $3.70–$4.00.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition On July 30, 2026, A. O. Smith Corporation (“the Company”) issued a news release announcing the Company’s results for the quarter ended June 30, 2026. A copy of the Company’s news release is attached as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”) and is incorporated by reference herein. Item 9.01 Financial Statements and Exhibits The following exhibit is being filed herewith: (99.1) News Release of A. O. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.